FCN1 and acute myeloid leukemia: Our findings also unveil FCN1’s dual prognostic role, acting as a protective factor in ACC, LUAD, SARC, and SKCM, while posing as a prognostic risk factor in ESCA, LUSC, STAD, and AML.